A video showing women arguing with a man went viral recently. It was claimed that the man, reportedly part of a right-wing group, disrupted Miss Rishikesh pageant rehearsals while objecting to the ...

Kala Bio, Inc. (NASDAQ:KALA), a biotech company with a market capitalization of $10.74 million and showing significant stock volatility, announced it received a written notice of default from Oxford ...

Navratri Ashtami is one of the most revered days of the celebration, which is celebrated in the form of Kanjak or Kumari Puja by worshipping young girls as a manifestation of the Goddess. The only ...

One sports star is a big fan of the move THE O2 Arena has changed its name to honour England Women’s Rugby World Cup success. It is the first time the iconic venue has changed name since O2 bought the ...

Thank God for the drama class kids. Many of them are unbearable, of course, but sometimes they grow up to be Lady Gaga. The Mayhem Ball, which last night stormed London’s O2 for the first of four ...

03:05, Tue, Sep 30, 2025 Updated: 03:05, Tue, Sep 30, 2025 There's another major update from UK network O2 and it could leave some UK customers needing to upgrade their smartphones. It's just been ...

The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. Gaga doesn’t so much re-invent herself as build an entire world ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Always be cautious before investing in a penny stock.

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Kala Pharmaceuticals ( (KALA)) has shared ...

Sept 29 (Reuters) - Kala Bio (KALA.O), opens new tab will stop developing its experimental treatment for a type of eye condition after it failed to meet the main goal in a mid-stage study, sending the ...

ARLINGTON, Mass. - Kala Bio, Inc. (NASDAQ:KALA), a $133.75 million market cap biotech company whose stock has surged 174.5% year-to-date, announced Monday that its Phase 2b clinical trial of KPI-012 ...

ARLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...